{"id":3730,"date":"2018-04-25T16:23:35","date_gmt":"2018-04-25T10:53:35","guid":{"rendered":"http:\/\/blog.gomedii.com\/?p=3730"},"modified":"2020-02-06T18:46:34","modified_gmt":"2020-02-06T13:16:34","slug":"fda-drug-approved-for-most-common-kidney-disease","status":"publish","type":"post","link":"https:\/\/gomedii.com\/blogs\/english\/international-health-news\/fda-drug-approved-for-most-common-kidney-disease\/","title":{"rendered":"First Drug Approved For Most Common Inherited Kidney Disease"},"content":{"rendered":"<h1 style=\"text-align: justify;\">USA Food and Drug Administration has approved the first drug to reduce kidney decline in patients with the most common hereditary kidney disease.<\/h1>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">Jynarque (jihn-AR&#8217;-kew) from the Japanese company Otsuka Pharmaceutical was confirmed on Tuesday for autosomal dominant polycystic kidney disease.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">The progressive genetic disorder is the fourth leading cause of kidney failure. It causes cysts full of fluid that develop and damage the kidneys.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">The FDA refused to approve it in 2013, but approved it after the drug maker completed an additional study. This one-year study of 1,370 patients with advanced disease showed that the decrease in kidney decline on average by 35% compared to counterfeit pills.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">Otsuka says the drug, also known as tolvaptan, will cost $ 13,041 a month without insurance.<\/p>\n<p style=\"text-align: justify;\">Jynarch can cause serious and even fatal liver damage, excessive urination and other side effects.<\/p>\n<hr \/>\n<hr \/>\n<h2><\/h2>\n<h2><\/h2>\n<h2 class=\"entry-title blog-entry-title\"><a href=\"https:\/\/gomedii.com\/blogs\/english\/health-care\/chocolate-increases-risk-of-kidney-stone\/\" target=\"_blank\" rel=\"bookmark noopener noreferrer\">Do You Know Chocolate Increases Risk of Kidney Stone<\/a><\/h2>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignleft wp-image-1742 size-medium\" src=\"\/wp-content\/uploads\/2018\/02\/Kidney-Stone_twitter-copy-300x150.png\" alt=\"Do You Know Chocolate Increases Risk of Kidney Stone\" width=\"300\" height=\"150\" srcset=\"https:\/\/english-blog.s3.amazonaws.com\/uploads\/2018\/02\/Kidney-Stone_twitter-copy-300x150.png 300w, https:\/\/english-blog.s3.amazonaws.com\/uploads\/2018\/02\/Kidney-Stone_twitter-copy-600x300.png 600w, https:\/\/english-blog.s3.amazonaws.com\/uploads\/2018\/02\/Kidney-Stone_twitter-copy-768x384.png 768w, https:\/\/english-blog.s3.amazonaws.com\/uploads\/2018\/02\/Kidney-Stone_twitter-copy.png 1024w, https:\/\/english-blog.s3.amazonaws.com\/uploads\/2018\/02\/Kidney-Stone_twitter-copy-732x366.png 732w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\">According to a research conducted by the <strong>University of Maryland Medical Center<\/strong> which reveals that dark chocolate contains some oxalates in it that promotes the increase in the risk of kidney stone.<\/p>\n<p><a href=\"https:\/\/gomedii.com\/blogs\/english\/health-care\/chocolate-increases-risk-of-kidney-stone\/\" target=\"_blank\" rel=\"noopener noreferrer\">Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>USA Food and Drug Administration has approved the first drug to reduce kidney decline in patients with the most common hereditary kidney disease. &nbsp; Jynarque (jihn-AR&#8217;-kew) from the Japanese company Otsuka Pharmaceutical was confirmed on Tuesday for autosomal dominant polycystic kidney disease. &nbsp; The progressive genetic disorder is the fourth leading cause of kidney failure.&nbsp;<\/p>\n<p><a class=\"btn btn-style\" href=\"https:\/\/gomedii.com\/blogs\/english\/international-health-news\/fda-drug-approved-for-most-common-kidney-disease\/\">Continue Reading<\/a><\/p>\n","protected":false},"author":3,"featured_media":3734,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[542],"tags":[2959,2960,2961,228],"yst_prominent_words":[2943,1355,2957,2945,2944,679,2340,2958,2942,2941,2940,2950,2946,630,909,2951,2949,2955,905],"_links":{"self":[{"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/posts\/3730"}],"collection":[{"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/comments?post=3730"}],"version-history":[{"count":12,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/posts\/3730\/revisions"}],"predecessor-version":[{"id":26025,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/posts\/3730\/revisions\/26025"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/media\/3734"}],"wp:attachment":[{"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/media?parent=3730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/categories?post=3730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/tags?post=3730"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/gomedii.com\/blogs\/english\/wp-json\/wp\/v2\/yst_prominent_words?post=3730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}